Precision medicine

#Biotech hubs #Drug discovery #Drug discovery hotspots #Life sciences #Precision medicine #UK

Whitepaper: Precision medicine and the role of ecosystems

A new whitepaper is now available to download for free from Bruntwood SciTech. This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s… Read More

#News

Whitepaper: Fuelling the future: Precision medicine innovation and the role of ecosystems
#Biotech hubs #Drug discovery #Drug discovery hotspots #Life sciences #Precision medicine #UK

Fuelling the future: Precision medicine innovation and the role of ecosystems

This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems, examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper,… Read More

#Resources

#AI #Biomarkers #Clinical trials #Collaboration #Digital biomarkers #Nucleai #Precision medicine #Proscia

Proscia teams up with Nucleai to improve access to AI biomarkers

Software company Proscia has partnered with spatial AI biomarker company Nucleai in a collaboration aimed at improving precision medicine biomarkers for clinical trials.   The companies are integrating Nucleai’s predictive biomarker solutions into Proscia’s Concentriq software platform and will make them available as part of Proscia’s precision medicine AI portfolio.    The… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Anti-inflammatory #Artificial intelligence (AI) #Cancer research #Covid-19 #EpicentRx #Immunology / Virology & Vaccines #Oncology #Polypharmacologic #Precision medicine #Protein binders #Therapeutic targets

New podcast on the significance of drug repurposing

This is the latest episode of the free DDW narrated podcast, titled “Why drug repurposing is so significant for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI use in repurposing drugs for Covid-19 and RRx-001: Jack… Read More

#News

Precision medicine
#Cell culture #Drug targets #Heart disease #Precision medicine

Partners explore precision medicine approach to heart disease  

PlaqueTec and the Welch research group at the Babraham Institute have announced the completion of their collaboration to evaluate lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec.  The project was funded by the UKRI-BBSRC Campus Innovation Award (CIA), via the Babraham Research Campus Collaboration… Read More

#News

Bowl of rice bran
#Japan #Nanomedicine / nanotechnology #Oncology #Precision medicine #Tokyo University of Science

Rice bran nanoparticles show promise as targeted cancer therapy

Researchers have discovered that nanoparticles derived from rice bran are both effective and safe for the treatment of cancer. Cancer therapies that employ nanoparticles can specifically target cancer cells, sparing healthy tissue. Recent studies have demonstrated that plant-derived nanoparticles (pdNPs) that have therapeutic effects… Read More

#Cancer Research #Editor's Choice #News

A scientist examines brain scans on a large screen
#CNS #Neurology #Neuropsychiatric disorders #Neuroscience #Precision medicine #PrecisionLife

The era of precision neuroscience

Listen to this article on the DDW Podcast: Dr Steve Gardner, CEO of the computational biology company PrecisionLife, explores the challenges of achieving precision medicine in complex CNS conditions and explains how new precision neuroscience approaches are benefitting pharmaceutical companies who are again investing in the field to develop better treatments… Read More

#Exclusive Content

Precision medicine
#Drug discovery #Funding #Precision medicine #Sano Genetics #Software

$11.4m raised to power a ‘precision medicine revolution’  

Sano Genetics, a software company working to accelerate precision medicine research, has raised $11.4 million in new funding, led by Plural with participation from existing investors including MMC Ventures, Episode 1 and Seedcamp.   Sano Genetics is developing software which combines genetic testing, recruitment, and long-term engagement in one platform, accelerating… Read More

#Business & Investment #News

#Cancer #Diagnostics #Drug discovery #Oncology #Precision medicine

Can liquid biopsies transform precision medicine?

Brett Swansiger, Chief Commercial Officer at ANGLE, discusses the importance of liquid biopsies in precision medicine trials for cancer.   Challenges in the oncology clinical trials space The oncology market is a key growth driver for the pharma industry, with global drug revenues expected to reach US$390 billion by 2027… Read More

#Cancer Research #Exclusive Content

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

#Breast cancer #Collaboration #Mayo Clinic #Oncology #Precision medicine #SimBioSys

US collaboration to advance precision drugs for breast cancer

Techbio SimBioSys and the Mayo Clinic have entered into a strategic collaboration to develop novel digital precision medicine solutions for breast cancer. The aim of the collaboration is to develop cloud-based clinical software tools that will support the end-to-end decision-making process for early-stage breast cancer patients, including drug selection and… Read More

#Business & Investment #News

Cancer Research
#Cancer research #Cancer Research Horizons #Precision medicine #Regulatory #Start-ups #Technology

Conversations from Cancer Research Horizons’ Innovation Summit 2023 

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. DDW’s Megan Thomas spoke to a range of attendees.   Trends for cancer research  … Read More

#Cancer Research #Exclusive Content #Opinion #Regulatory

#Cancer research #Cancer Research Horizons #Cancer Research UK #Collaboration #Guardant Health #Precision medicine

CRUK and Guardant collaborate on precision cancer drugs

Cancer Research UK (CRUK), Cancer Research Horizons, and precision oncology company Guardant Health have launched a collaboration to advance cancer treatment. The agreement will enable the parties to discuss opportunities for collaboration to support the charity’s research and clinical development activities, focusing primarily on its clinical trials run by its… Read More

#Business & Investment #Cancer Research #News

Cancer immunotherapy
#Cancer immunotherapy #Drug discovery #eBook #Immunotherapy #Oncology #Precision medicine

Where are the latest breakthroughs in immunotherapy?

The latest in the DDW eBook series ‘Immunotherapy: Where are the advances and breakthroughs?‘ is now available for download. This 24-page eBook sponsored by Sino Biological looks at the advances and breakthroughs taking place within immunotherapy. Download this exclusive eBook to learn more about: Advances in cancer… Read More

#News

Immunotherapy eBook
#Cancer immunotherapy #Drug discovery #eBook #Immunotherapy #Oncology #Precision medicine

Immunotherapy: Where are the advances and breakthroughs?

This 24-page eBook sponsored by Sino Biological looks at the advances and breakthroughs taking place within immunotherapy. Download this exclusive eBook to learn more about: Advances in cancer care: Where are the advances in treatments for triple-negative breast cancer? Drug development: Five years of oncology developments Why immunotherapy is here… Read More

#DDW eBooks #Intelligence

#Ageing #Cancer research #Epigenetics #Gene regulation #HKG Epitherapeutics #Precision medicine

The epigenetic edge: Harnessing precision medicine’s potential 

HKG Epitherapeutics is a biotechnology company developing novel tools for the early detection of cancer and promoting healthy aging. Founder Dr Moshe Szyf Founder shares the potential of harnessing precision medicine.  Embarking on a new era of medicine  The advent of genomics has ushered in the era of personalised medicine,… Read More

#Business & Investment #Exclusive Content #Opinion